EichorEICHOR
Location: Heidelberg Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Heidelberg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Austin Health · Eli Lilly and Company · NCT07218380
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · University Hospital Heidelberg · Joseph Broderick, MD · NCT07227246
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Heidelberg University Hospital · Pfizer · NCT07028853
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Universitätsklinikum Heidelberg AöR · Princess Maxima Center for Pediatric Oncology · NCT05327894
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Austin Health · Bristol-Myers Squibb · NCT07106762
Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NA · Austin Health · University of Melbourne · NCT07055542
Evaluation of Optical Coherence Tomography in Dentistry
NA · Department of Orthodontics and Dentofacial Orthopaedics, Uni · University of Heidelberg Medical Center · NCT03753256
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Universitaetsklinikum Heidelberg · Miltenyi Biomedicine GmbH · NCT04844866
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Universitätsklnikum Heidelberg · AGO Study Group · NCT05009082
PulseSelect™ PFA Global Registry
Phase N/A · Universitätsklinikum Heidelberg · Medtronic Cardiac Ablation Solutions · NCT06393920
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Thoraxklinik-Heidelberg gGmbH · Pfizer · NCT07073820
An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Phase 1/Phase 2 · Austin Health · Pathios Therapeutics Pty Ltd · NCT06634849
A Non-interventional, Prospective Study With Benralizumab
Phase N/A · Research Site · AstraZeneca · NCT06422078
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Austin Health · Hoffmann-La Roche · NCT06793215
Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency
Phase N/A · University Children's Hospital · Boston Children's Hospital · NCT03758521
Perturbation-Based Treadmill Training to Prevent Unrecovered Falls in Geriatric Patients
NA · Geriatric Center, Heidelberg University Hospital, Agaplesion · University of Oldenburg · NCT06652828
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Austin Health, Heidelberg Repatriation Hospital · Amgen · NCT07037433
The Myeloid Neoplasms Biology and Outcome Project
Phase N/A · UHHeidelberg · University Hospital Heidelberg · NCT05074316
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · Austin Hospital · Monash University · NCT05678621
Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib +
Phase N/A · Research Site · AstraZeneca · NCT06380738
DV 100 as a Framework for the Hospital Incident Command System
Phase N/A · University Hospital Heidelberg · University Hospital Heidelberg · NCT06913010
Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Respon
NA · Brustzentrum Heidelberg · Klinik Hirslanden, Zurich · NCT04289935
PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers
EARLY_Phase 1 · University Hospital Department of Clinical Pharmacology and · German Cancer Research Center · NCT05208710
Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening
Phase N/A · University Children's Hospital Heidelberg, Cystic Fibrosis C · Heidelberg University · NCT02270476
A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · HPK Heidelberger Praxisklinik · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615
Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases
Phase 2 · University Hospital of Heidelberg, Radiation Oncology · University Hospital Heidelberg · NCT05027711
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Austin Health · Eli Lilly and Company · NCT06890598
Look up another city
Look up another condition